Turner Medtech Joins the Prestigious Inc. 5000 List
Orem, Utah – [Date] Turner Medtech, a leading innovator in the medical device and biotechnology sector, is proud to announce its inclusion in the esteemed Inc. 5000 list, a hallmark of entrepreneurial success. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Turner Medtech's inclusion in the Inc. 5000 list not only reflects the company's financial growth but also underscores the significant contributions of its dedicated team members. Their commitment to innovation and excellence has been pivotal in driving the company's success.
- Being included in the prestigious Inc. 5000 list is a significant achievement highlighting the company's growth and impact in the small business segment.
- Turner Medtech offers a full range of services from design support and rapid prototyping to commercialization, positioning itself as a leading resource for medical device components and product manufacturing.
About Turner MedTech
Turner MedTech is an ISO 13485 certified contract manufacturer, supporting companies in the transfer of medical and other technology products into manufacturing. From design support and rapid prototyping to process development and on to commercialization through product assembly and testing, Turner MedTech is rapidly emerging as the go-to resource for prototyping and contract manufacturing of medical device components and products.
For more information, visit Turner MedTech at 1119 South 1680 West Orem, UT 84058, Direct phone: 1-801-796-2951 or at www.turnermedtech.com.
Contacts:
Chelli Miller
219-921-6823
[email protected]
Source: Turner Medtech
Distributed by: Reportable, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
- Gartner Marketing Survey Finds 34% of U.S. Consumers Are Willing to Use GenAI for Holiday Gift Recommendations
- Microelectronics US Announces Steering Committee Ahead of Inaugural 2027 Austin Event
Create E-mail Alert Related Categories
Press Releases, ReportableSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share